[HTML][HTML] Immunogenicity and reactogenicity of heterologous ChAdOx1 nCoV-19/mRNA vaccination

T Schmidt, V Klemis, D Schub, J Mihm, F Hielscher… - Nature medicine, 2021 - nature.com
Heterologous priming with the ChAdOx1 nCoV-19 vector vaccine followed by boosting with
a messenger RNA vaccine (BNT162b2 or mRNA-1273) is currently recommended in …

[HTML][HTML] Facing depression with botulinum toxin: a randomized controlled trial

…, C de Boer, N Kalak, J Beck, T Götz, T Schmidt… - Journal of psychiatric …, 2012 - Elsevier
Positive effects on mood have been observed in subjects who underwent treatment of
glabellar frown lines with botulinum toxin and, in an open case series, depression remitted or …

[HTML][HTML] Cellular immunity predominates over humoral immunity after homologous and heterologous mRNA and vector-based COVID-19 vaccine regimens in solid …

T Schmidt, V Klemis, D Schub, S Schneitler… - American Journal of …, 2021 - Elsevier
Knowledge on the immunogenicity of vector-based and mRNA-vaccines in solid organ
transplant recipients is limited. Therefore, SARS-CoV-2–specific T cells and antibodies were …

[HTML][HTML] Evolutionarily conserved herpesviral protein interaction networks

…, SV Rajagopala, B Titz, A Baiker, T Schmidt… - PLoS …, 2009 - journals.plos.org
Herpesviruses constitute a family of large DNA viruses widely spread in vertebrates and
causing a variety of different diseases. They possess dsDNA genomes ranging from 120 to 240 …

[HTML][HTML] Comparative immunogenicity and reactogenicity of heterologous ChAdOx1-nCoV-19-priming and BNT162b2 or mRNA-1273-boosting with homologous …

V Klemis, T Schmidt, D Schub, J Mihm, S Marx… - Nature …, 2022 - nature.com
Comparative analyses of the immunogenicity and reactogenicity of homologous and
heterologous SARS-CoV-2 vaccine-regimens will inform optimized vaccine strategies. Here we …

Changing the use of HIV pre-exposure prophylaxis among men who have sex with men during the COVID-19 pandemic in Melbourne, Australia

…, JS Hocking, JJ Ong, T Schmidt… - Open forum …, 2020 - academic.oup.com
We surveyed 204 men who have sex with men (MSM) who were pre-exposure prophylaxis (PrEP)
users. One in 4 daily PrEP users stopped taking PrEP during the COVID-19 pandemic, …

[HTML][HTML] High levels of SARS-CoV-2–specific T cells with restricted functionality in severe courses of COVID-19

…, SL Becker, U Sester, M Sester, T Schmidt - JCI insight, 2020 - ncbi.nlm.nih.gov
BACKGROUND Patients infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
differ in the severity of disease. We hypothesized that characteristics of SARS-…

[HTML][HTML] Prolonged course of COVID-19-associated pneumonia in a B-cell depleted patient after rituximab

…, S Roth, M Ahlgrimm, M Sester, T Schmidt… - Frontiers in …, 2020 - frontiersin.org
Patients with pre-existing comorbidities and immunosuppression are at greater risk for
SARS-CoV-2 infection and severe manifestations of COVID-19. This also includes cancer patients…

NVX-CoV2373-induced cellular and humoral immunity towards parental SARS-CoV-2 and VOCs compared to BNT162b2 and mRNA-1273-regimens

F Hielscher, T Schmidt, V Klemis, A Wilhelm… - Journal of Clinical …, 2022 - Elsevier
Background The NVX-CoV2373-vaccine has recently been licensed, although knowledge on
vaccine-induced humoral and cellular immunity towards the parental strain and variants of …

[HTML][HTML] Differences in SARS-CoV-2 specific humoral and cellular immune responses after contralateral and ipsilateral COVID-19 vaccination

L Ziegler, V Klemis, T Schmidt, S Schneitler, C Baum… - …, 2023 - thelancet.com
Background Individual doses of dual-dose vaccine-regimens are sequentially administered
into the deltoid muscle, but little attention has so far been paid to the immunological effects of …